ANGO vs PFE · rev $292.5M vs P/E 20, rev $62.58B
AngioDynamics Inc (ANGO) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ANGO currently screens at market cap $378.5M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ANGO and PFE stock pages for the full models.
Not investment advice.